Review on Gastroretentive Systems for Olmesartan Medoxomil
DOI:
https://doi.org/10.22270/ajprd.v13i5.1634Abstract
Olmesartan Medoxomil, an angiotensin receptor blocker, is widely used to treat hypertension and cardiovascular diseases but suffers from low bioavailability, short half-life, and frequent dosing requirements. Gastroretentive drug delivery systems (GRDDS) offer a promising solution by prolonging gastric residence, improving solubility, and enhancing absorption. This review explores various GRDDS strategies suitable for Olmesartan Medoxomil, including floating, swelling, mucoadhesive, high-density, and magnetic systems. It discusses the polymers and excipients involved, such as hydrophilic polymers (HPMC, sodium alginate), hydrophobic polymers (ethyl cellulose), gas-generating agents, and density enhancers. Mechanisms like buoyancy, swelling, mucoadhesion, sedimentation, and magnetic localization are elaborated to explain their role in enhancing retention. Evaluation parameters like floating lag time, swelling index, and drug release kinetics are also summarized. The review highlights formulation challenges and suggests future directions, including smart polymers, nanocarriers, and personalized medicine, aimed at improving therapeutic efficacy and patient compliance.
Downloads
References
Burnier M. Angiotensin II type 1 receptor blockers. Circulation. 2001;103(6):904–12.
Garg R, Gupta GD. Gastroretentive drug delivery systems. Business Briefing: Pharmatech. 2003;1–6.
Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63(3):235–59.
Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery systems. Expert Opin Drug Deliv. 2006;3(2):217–33.
Sarangi D, Sahoo SK, Sahoo S. An assessment of Olmesartan Medoxomil tablet formulations: A review. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021;13(3):5-12.
Sriamornsak P. Swelling, erosion and release behavior of alginate-based matrix tablets. European Journal of Pharmaceutics and Biopharmaceutics. 2007;65(3):235-243.
Sarojini S, Rani R, Reddy Y. Formulation development of Olmesartan Medoxomil mucoadhesive buccal films. Asian Journal of Pharmaceutics. 2016;10(3):229-234.
Kota RK, Reddy Y. Development and evaluation of Olmesartan Medoxomil floating microspheres. International Journal of Pharmaceutical Sciences and Nanotechnology. 2017;10(3):3565-3570.
Deshmukh PK, Rathi M, Chaturvedi SC. Formulation and evaluation of floating matrix tablets of Olmesartan Medoxomil using HPMC and carbopol. Journal of Drug Delivery Science and Technology. 2018;45:337–345.
Patil P, Sawant K. Development of mucoadhesive gastroretentive tablets of Olmesartan Medoxomil using chitosan and sodium alginate. Asian Journal of Pharmaceutical and Clinical Research. 2019;12(8):112–119.
Rathi M, Sharma S, Singh S. Role of hydrophilic and hydrophobic polymers in sustained release gastroretentive tablets. International Journal of Pharmaceutical Sciences Review and Research. 2017;44(1):68–74.
Sinha VR, Kumria R. Polymers in controlled drug delivery systems: a review. Drug Delivery. 2001;8(1):53–62.
Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int J Pharm. 1996;136(1–2):117–139.
Kim EH, Park JB, Choi JS, et al. Gastroretentive drug delivery systems: a review on floating, mucoadhesive, and expandable approaches. J Pharm Investig. 2020;50(4):345–362.
Vyas GK, Sharma H, Vyas B, Sharma A, Sharma M. Efficacy of ethanolic extracts for two plants on wound healing in diabetic albino rats. Chettinad Health City Med J. 2023;12(2):46-55.
Bansal M, Verma A, Pawar A. Gastroretentive drug delivery systems: a review on evaluation parameters. World J Pharm Res. 2016;5(12):1124–1137.
Vyas SP, Khar RK. Controlled drug delivery: concepts and advances. 2nd ed. New Delhi: Vallabh Prakashan; 2012. p. 301–324.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Hursh Gupta, Manmohan Sharma, Anil Ahuja, Shashank Tiwari
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
. 